Our goal is to find a cure for pediatric low-grade gliomas

Powder Gate Discovery (PGDM LLC) advises a $100mm venture capital fund, Mulberry Biolab LLC. We are dedicated to funding innovative treatments for pediatric glioma. The firm’s sole mission is to aid in the development of a cure for children with low-grade glioma. We invest across the entire treatment development life cycle, from early preclinical grants to company creation and venture capital investments, with a check size range of $1-10 million.